P3 Health Partners [PIII] vs Brookdale Senior [BKD] Detailed Stock Comparison
P3 Health Partners
NASDAQ
Loading...
Brookdale Senior
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: P3 Health Partners wins in 6 metrics, Brookdale Senior wins in 11 metrics, with 0 ties. Brookdale Senior appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | P3 Health Partners | Brookdale Senior | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.18 | -9.06 | Brookdale Senior |
| Price-to-Book Ratio | 0.64 | 18.15 | P3 Health Partners |
| Debt-to-Equity Ratio | 221.06 | 5,198.71 | P3 Health Partners |
| PEG Ratio | 0.00 | -1.54 | Brookdale Senior |
| EV/EBITDA | -0.98 | 16.07 | P3 Health Partners |
| Profit Margin (TTM) | -9.99% | -7.95% | Brookdale Senior |
| Operating Margin (TTM) | -9.59% | 3.34% | Brookdale Senior |
| EBITDA Margin (TTM) | N/A | 3.34% | N/A |
| Return on Equity | -141.55% | -108.24% | Brookdale Senior |
| Return on Assets (TTM) | -24.31% | 0.88% | Brookdale Senior |
| Free Cash Flow (TTM) | $-110.13M | $-35.07M | Brookdale Senior |
| 1-Year Return | -54.23% | 30.00% | Brookdale Senior |
| Price-to-Sales Ratio (TTM) | 1.20 | 0.63 | Brookdale Senior |
| Enterprise Value | $225.13M | $7.21B | Brookdale Senior |
| EV/Revenue Ratio | 0.15 | 2.36 | P3 Health Partners |
| Gross Profit Margin (TTM) | N/A | 26.56% | N/A |
| Revenue per Share (TTM) | $449 | $13 | P3 Health Partners |
| Earnings per Share (Diluted) | $-51.33 | $-1.05 | Brookdale Senior |
| Beta (Stock Volatility) | 0.84 | 0.90 | P3 Health Partners |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
P3 Health Partners vs Brookdale Senior Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| P3 Health Partners | 1.76% | -11.37% | 1.41% | 35.58% | -0.57% | -30.80% |
| Brookdale Senior | -4.28% | -3.36% | 5.64% | 17.84% | 28.75% | 59.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| P3 Health Partners | -54.23% | -96.42% | -98.23% | -98.23% | -98.23% | -98.23% |
| Brookdale Senior | 30.00% | 67.57% | 187.86% | -64.74% | -50.88% | -68.58% |
News Based Sentiment: P3 Health Partners vs Brookdale Senior
P3 Health Partners
News based Sentiment: MIXED
September presented a mixed bag for P3 Health Partners, with positive analyst ratings and a brief stock rally offset by institutional selling and a projected revenue decline. The company is actively engaging with investors, but significant financial challenges remain, creating a high-risk, high-reward investment scenario.
Brookdale Senior
News based Sentiment: MIXED
Brookdale experienced a stock rally and positive institutional investment alongside disappointing Q2 financial results and a cautious analyst outlook. The appointment of a new CEO adds another layer to the evolving investment story, making this a significant but complex month for the company.
Performance & Financial Health Analysis: P3 Health Partners vs Brookdale Senior
| Metric | PIII | BKD |
|---|---|---|
| Market Information | ||
| Market Cap | $1.76B | $1.94B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,590 | 3,273,653 |
| 90 Day Avg. Volume | 8,277 | 2,916,288 |
| Last Close | $8.65 | $8.06 |
| 52 Week Range | $5.80 - $26.00 | $4.45 - $8.66 |
| % from 52W High | -66.73% | -6.93% |
| All-Time High | $16.73 (Dec 06, 2021) | $54.25 (Jun 05, 2006) |
| % from All-Time High | -48.30% | -85.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.05% |
| Quarterly Earnings Growth | -0.06% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | -0.08% |
| Operating Margin (TTM) | -0.10% | 0.03% |
| Return on Equity (TTM) | -1.42% | -1.08% |
| Debt to Equity (MRQ) | 221.06 | 5,198.71 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.60 | $0.44 |
| Cash per Share (MRQ) | $11.81 | $1.06 |
| Operating Cash Flow (TTM) | $-129,955,000 | $218.62M |
| Levered Free Cash Flow (TTM) | $-1,812,750 | $-317,427,360 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: P3 Health Partners vs Brookdale Senior
| Metric | PIII | BKD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.18 | -9.06 |
| Forward P/E | -41.19 | -13.43 |
| PEG Ratio | 0.00 | -1.54 |
| Price to Sales (TTM) | 1.20 | 0.63 |
| Price to Book (MRQ) | 0.64 | 18.15 |
| Market Capitalization | ||
| Market Capitalization | $1.76B | $1.94B |
| Enterprise Value | $225.13M | $7.21B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.15 | 2.36 |
| Enterprise to EBITDA | -0.98 | 16.07 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.90 |
| Book Value per Share (MRQ) | $13.60 | $0.44 |
Financial Statements Comparison: P3 Health Partners vs Brookdale Senior
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PIII | BKD |
|---|---|---|
| Revenue/Sales | $373.23M | $812.94M |
| Cost of Goods Sold | N/A | $597.02M |
| Gross Profit | N/A | $215.92M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-38.09M | $15.44M |
| EBITDA | $-16.72M | $113.27M |
| Pre-Tax Income | $-43.17M | $-43.31M |
| Income Tax | $1.07M | $-271,000 |
| Net Income (Profit) | $-44.25M | $-43.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PIII | BKD |
|---|---|---|
| Cash & Equivalents | $40.08M | $239.73M |
| Total Current Assets | $191.44M | $454.03M |
| Total Current Liabilities | $507.03M | $555.71M |
| Long-Term Debt | $117.10M | $5.43B |
| Total Shareholders Equity | $121.08M | $148.14M |
| Retained Earnings | $-523.67M | $-4.10B |
| Property, Plant & Equipment | $1.08M | $2.01B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PIII | BKD |
|---|---|---|
| Operating Cash Flow | $-43.46M | $27.90M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-33.47M | $-18.42M |
| Debt Repayment | $-341,000 | $-70.34M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PIII | BKD |
|---|---|---|
| Shares Short | 23,909 | 12.25M |
| Short Ratio | 3.38 | 4.49 |
| Short % of Float | 0.07% | 0.05% |
| Average Daily Volume (10 Day) | 6,590 | 3,273,653 |
| Average Daily Volume (90 Day) | 8,277 | 2,916,288 |
| Shares Outstanding | 3.26M | 200.02M |
| Float Shares | 1.23M | 233.91M |
| % Held by Insiders | 0.62% | 0.03% |
| % Held by Institutions | 0.11% | 0.99% |
Dividend Analysis & Yield Comparison: P3 Health Partners vs Brookdale Senior
| Metric | PIII | BKD |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |